文献速递艾滋病与性传播感染

1990-2015年HIV-1全球与区域分子流行病学:系统综述、全球调查与趋势分析

Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis.
PubMed 文献 · Lancet Infect Dis · 2018-11-30

BACKGROUND: Global genetic diversity of HIV-1 is a major challenge to the development of HIV vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and recombinants during 1990-2015.…

要点

  • 2005-15年全球重组体比例持续上升,B亚型增加而C、G及CRF02_AG下降。

核心结论

  • 全球与区域HIV-1多样性复杂且持续演变,是HIV疫苗研发的主要挑战,全球分子流行病学监测对疫苗设计、试验与实施仍至关重要。

研究设计与样本

  • 系统综述联合全球调查,检索PubMed、EMBASE、CINAHL与Global Health并收集未发表分型数据,PROSPERO注册号CRD42017067164。

主要发现

  • 全球层面2005-15年B亚型增加,A、D亚型稳定,C、G亚型及CRF02_AG下降,CRF01_AE、其他CRF与URF上升。

关键数值与推荐

  • 亚型分布按各国UNAIDS估计的HIV感染者数加权,生成各时段的区域与全球多样性估计。
  • 主要结局为被判定为A、B、C、D、F、G、H、J、K亚型、CRF与URF的样本数。

临床怎么用

  • 可用于了解不同区域HIV-1亚型与重组体构成,为疫苗设计、试验选址与实施提供分子流行病学背景。

局限性

  • 原文摘要未报告各区域亚型分布的具体数值,区域层面结论需查阅全文。
  • 分析依赖已发表与调查获得的分型数据及UNAIDS感染者数估计,摘要未描述数据质量与偏倚控制细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Global genetic diversity of HIV-1 is a major challenge to the development of HIV vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and recombinants during 1990-2015. METHODS: We searched PubMed, EMBASE (Ovid), CINAHL (Ebscohost), and Global Health (Ovid) for HIV-1 subtyping studies published between Jan 1, 1990, and Dec 31, 2015. We collected additional unpublished HIV-1 subtyping data through a global survey. We included prevalence studies with HIV-1 subtyping data collected during 1990-2015. We grouped countries into 14 regions and analysed data for four time periods (1990-99, 2000-04, 2005-09, and 2010-15). The distribution of HIV-1 subtypes, circulating recombinant forms (CRFs), and unique recombinant forms (URFs) in individual countries was weighted according to the UNAIDS estimates of the number of people living with HIV (PLHIV) in each country to generate regional and global estimates of HIV-1 diversity in each time period. The primary outcome was the number of samples designated as HIV-1 subtypes A, B, C, D, F, G, H, J, K, CRFs, and URFs. The systematic review is registered with PROSPERO, number CRD42017067164. FINDINGS: This systematic review and global survey yielded 2203 datasets with 383 519 samples from 116 countries in 1990-2015. Globally, subtype C accounted for 46·6% (16 280 897/34 921 639 of PLHIV) of all HIV-1 infections in 2010-15. Subtype B was responsible for 12·1% (4 235 299/34 921 639) of infections, followed by subtype A (10·3%; 3 587 003/34 921 639), CRF02_AG (7·7%; 2 705 110/34 921 639), CRF01_AE (5·3%; 1 840 982/34 921 639), subtype G (4·6%; 1 591 276/34 921 639), and subtype D (2·7%; 926 255/34 921 639). Subtypes F, H, J, and K combined accounted for 0·9% (311 332/34 921 639) of infections. Other CRFs accounted for 3·7% (1 309 082/34 921 639), bringing the proportion of all CRFs to 16·7% (5 844 113/34 921 639). URFs constituted 6·1% (2 134 405/34 921 639), resulting in recombinants accounting for 22·8% (7 978 517/34 921 639) of all global HIV-1 infections. The distribution of HIV-1 subtypes and recombinants changed over time in countries, regions, and globally. At a global level during 2005-15, subtype B increased, subtypes A and D were stable, and subtypes C and G and CRF02_AG decreased. CRF01_AE, other CRFs, and URFs increased, leading to a consistent increase in the global proportion of recombinants over time. INTERPRETATION: Global and regional HIV diversity is complex and evolving, and is a major challenge to HIV vaccine development. Surveillance of the global molecular epidemiology of HIV-1 remains crucial for the design, testing, and implementation of HIV vaccines. FUNDING: None.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hemelaar J, Elangovan R, Yun J, et al. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2018. PMID: 30509777. doi:10.1016/S1473-3099(18)30647-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。